Does Systemic Metformin Have a Role in Treating Melasma?
Authors:
- 28 February 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 50 (4) , 366-371
Abstract
BACKGROUND: Melasma is a common pigmentary condition that affects the patients' quality of life and all the prescribed treatment options till now are not satisfactory, especially in dark-skinned patients. OBJECTIVE: To evaluate the efficacy and safety of systemic metformin (1,000 mg and 500 mg) combined with trichloroacetic acid (TCA) peeling versus TCA alone in the treatment of melasma. PATIENTS AND METHODS: The study included 60 melasma patients divided into 3 groups: Group A received systemic metformin (1000 mg/d), Group B received systemic metformin (500 mg/d) and Group C received placebo. The 3 treatment groups were treated by TCA 25% over the whole face bimonthly for a total of 6 sessions. Melasma area and severity index (MASI), and Melasma impact Quality of life Scale (MELASQOL) were used to assess the outcome. RESULTS: There was a statistically significant decrease in the MASI, and the MELASQOL in the 3 studied groups after treatment with significantly better improvement in Group (A) than Group (C) (p = .045). CONCLUSION: Systemic metformin is a safe and promising therapeutic option for treating melasma.Keywords
This publication has 24 references indexed in Scilit:
- Platelet-rich plasma is a useful therapeutic option in melasmaJournal of Dermatological Treatment, 2018
- Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasmaJournal of the American Academy of Dermatology, 2018
- Universal Trichloroacetic Acid Peel Technique for Light and Dark SkinJAMA Facial Plastic Surgery, 2017
- A review of laser and light therapy in melasmaInternational Journal of Women's Dermatology, 2017
- Inhibition of Melanogenesis by the Antidiabetic MetforminJournal of Investigative Dermatology, 2014
- Q-Switched NdDermatologic Surgery, 2014
- Melasma: A comprehensive updateJournal of the American Academy of Dermatology, 2011
- Melasma: Treatment evaluationJournal of Cosmetic and Laser Therapy, 2009
- Validation of a melasma quality of life questionnaire for the Turkish language: The MelasQoL-TR studyJournal of Dermatological Treatment, 2009
- Topical Retinoic Acid (Tretinoin) for Melasma in Black PatientsArchives of Dermatology, 1994